Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARRY-371797 in LMNA-Related Dilated Cardiomyopathy
NCT02057341Phase 2Completed
- Sponsor
- Pfizer
- Start
- Feb 2014
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of emprumapimod in LMNA-related dilated cardiomyopathy, sponsored by Pfizer. Started Feb 2014; status: completed.
02
Drugs
emprumapimod
03
Conditions
LMNA-related dilated cardiomyopathy
Beyond the preview
Go deeper on NCT02057341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02057341.